Mitigating COVID-19 Transmission: A Machine Learning Approach to Contact Tracing Optimization

Vijaya Lakshmi Pavani Molli

Abstract


In the battle against the COVID-19 pandemic, effective contact tracing plays a pivotal role in controlling transmission. Traditional contact tracing methods are resource-intensive and may not keep pace with the rapidly evolving nature of the virus. This paper proposes a novel approach to optimize contact tracing using machine learning (ML) algorithms. By leveraging ML techniques, we aim to enhance the accuracy and efficiency of contact tracing efforts, thereby reducing transmission rates. Our proposed framework integrates real-time data streams, including geographical, demographic, and epidemiological information, to identify and prioritize individuals at higher risk of exposure. Through predictive modeling and network analysis, we can optimize resource allocation for testing and quarantine measures. Additionally, our approach facilitates early detection of potential outbreaks and enables targeted interventions to contain the spread of the virus. We present a case study demonstrating the feasibility and effectiveness of our ML-based contact tracing system in a simulated pandemic scenario. The results underscore the potential of machine learning in augmenting public health strategies to combat COVID-19 and future infectious diseases.


Full Text:

PDF

References


Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020). How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet, 395(10228), 931-934.

Hellewell, J., Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W., ... & Kucharski, A. J. (2020). Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health, 8(4), e488-e496.

Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Abeler-Dörner, L., ... & Fraser, C. (2020). Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science, 368(6491), eabb6936.

Kucharski, A. J., Russell, T. W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., ... & Davies, N. (2020). Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The Lancet Infectious Diseases, 20(5), 553-558.

Wu, J. T., Leung, K., & Leung, G. M. (2020). Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet, 395(10225), 689-697.

Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., ... & Lessler, J. (2020). The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine, 172(9), 577-582.

Ferguson, N. M., Laydon, D., Nedjati-Gilani, G., Imai, N., Ainslie, K., Baguelin, M., ... & Ghani, A. C. (2020). Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College COVID-19 Response Team, 20.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727-733.

Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., ... & Hoelscher, M. (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine, 382(10), 970-971.

World Health Organization. (2020). Novel coronavirus (2019-nCoV) situation report–1. World Health Organization.

Remuzzi, A., & Remuzzi, G. (2020). COVID-19 and Italy: what next? The Lancet, 395(10231), 1225-1228.

World Health Organization. (2020). Coronavirus disease 2019 (COVID-19) situation report–51. World Health Organization.

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., ... & Xing, X. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382(13), 1199-1207.

Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In StatPearls [Internet]. StatPearls Publishing.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.

Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 323(13), 1239-1242.

Adhikari, S. P., Meng, S., Wu, Y. J., Mao, Y. P., Ye, R. X., Wang, Q. Z., ... & Zhou, H. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious Diseases of Poverty, 9(1), 1-12.

WHO-China Joint Mission. (2020). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). World Health Organization.

Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., ... & Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708-1720.

Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. The Lancet, 395(10223), 470-473.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 International Journal of Machine Learning for Sustainable Development

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Impact Factor : 

JCR Impact Factor: 5.9 (2020)

JCR Impact Factor: 6.1 (2021)

JCR Impact Factor: 6.7 (2022)

JCR Impact Factor: 7.6 (2023)

JCR Impact Factor: 8.6 (2024)

JCR Impact Factor: Under Evaluation (2025)

A Double-Blind Peer-Reviewed Refereed Journal